PBS Biotech, a Camarillo, CA-based single-use bioreactor manufacturer and process development services provider, raised $22M in funding.
The round was led by Avego Management, with participation from BroadOak Capital Partners. In conjunction with the funding, Jerry Liao, Vice President at Avego, has joined the Board of Directors at PBS.
The company intends to use the funds to improve its products portfolio, expand its process development services capability, and increase customer support for global cell therapy clients.
Led by CEO Brian Lee, PBS Biotech is a manufacturer of single-use bioreactor systems and provider of process development services. Its bioreactors utilize proprietary Vertical-Wheel technology to create homogeneous and scalable mixing conditions for a variety of sensitive cell therapy products and cell culture applications.
FinSMEs
09/01/2023